EP Patent

EP2453742A4 — IBUPROFEN TREATMENT INTRAVENOUSLY

Assigned to Cumberland Pharmaceuticals Inc · Expires 2012-09-05 · 14y expired

What this patent protects

Patent listed against Advil.

Drugs covered by this patent

Advil (ibuprofen) · Generic (originally Boots Group)

Patent Metadata

Patent number: EP2453742A4
Jurisdiction: EP
Classification: —
Expires: 2012-09-05
Drug substance claim: No
Drug product claim: No
Assignee: Cumberland Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.